Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
psychiatric drugs
Pharma
After Avadel setback, Lundbeck signals future M&A rigor
While some analysts have questioned Lundbeck’s prospects following a major patent cliff, company leadership says it will prioritize strategic fit.
Angus Liu
Jan 22, 2026 11:13am
Otsuka, Lundbeck's Rexulti snubbed by FDA in PTSD
Sep 22, 2025 4:42pm
Few psych drugs from past decade are on HCPs' radars: survey
Apr 10, 2025 8:15am
MS meds send CNS market toward strongest growth in years
Mar 26, 2025 10:48am
